Skip to main content
Figure 1 | BMC Endocrine Disorders

Figure 1

From: The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period

Figure 1

Mean lipid changes in patients with T2D according to BMI reduction quartiles. Lipid changes in patients with T2D stratified according to BMI reduction quartile (1-4). Quartile 1 represents the least reduction in BMI whereas quartile 4 represents the greatest. Mean lipid values are listed for each quartile with 95% confidence intervals. All values are measured in mmol/L. 13 patients with unknown risk category were excluded.

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us